[MRI in giant cell (temporal) arteritis]

T A Bley1, M Uhl, M Markl

  • 1Röntgendiagnostik, Uniklinik Freiburg, Huhstetterstrasse 55, 79106 Freiburg. thorsten.bley@uniklinik-freiburg.de

Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin
|July 28, 2007
PubMed

Insights

High-resolution MRI offers a noninvasive method for diagnosing giant cell arteritis, visualizing cranial and extracranial arteries. This advanced imaging facilitates early detection and monitoring of treatment response, preventing complications like blindness.

Area of Science:

  • Vascular Imaging
  • Rheumatology
  • Diagnostic Radiology

Background:

  • Giant cell arteritis (GCA) presents diagnostic challenges, with delayed treatment increasing the risk of blindness.
  • Early and accurate diagnosis is crucial for effective management of GCA.

Purpose of the Study:

  • To evaluate an optimized MRI protocol for the noninvasive diagnosis of giant cell arteritis.
  • To assess the capability of high-resolution MRI in visualizing cranial and extracranial arterial involvement in GCA.

Main Methods:

  • Utilized an optimized, high-resolution MRI protocol with submillimeter in-plane resolution.
  • Performed post-contrast imaging of superficial cranial arteries and MR angiography of the aorta and supra-aortic arteries.
  • Assessed image quality at 1.5T and 3T, noting superiority at 3T due to higher signal-to-noise ratios.

Main Results:

  • High-resolution MRI clearly distinguished inflamed from healthy arterial segments.
  • The protocol enabled detailed visualization of the lumen and arterial wall, assessing cranial and extracranial involvement patterns.
  • MR signs of inflammation significantly decreased with successful long-term treatment.

Conclusions:

  • Optimized high-resolution MRI provides a reliable, noninvasive method for diagnosing GCA.
  • This technique offers detailed assessment of cranial and extracranial vasculature, independent of operator expertise.
  • MRI aids in monitoring treatment response, showing resolution of vascular inflammation over time.